Rajiv Gandhi Centre for Biotechnology appoints Chandrabhas Narayana as new director
Prof. Chandrabhas Narayana nominated as the new director for Rajiv Gandhi Centre for Biotechnology (RGCB) Narayana has served as professor...
Latest Post
Non-medical staff of Gurugram hospital rapes TB patient in ICU
Trigger warning: Rape and sexual assault The non-medical, outsourced staff of Fortis hospital has been identified as the perpetrator. The...
The medical tourism industry in Kolkata suffers Rs.377 crore loss during the lockdown
Approximately 10,000 people from Bangladesh and Nepal arrive in the city each month for medical consultations. The medical tourism industry...
Doctors of NDMC-run hospitals persist on a hunger strike and continued protests
The strike persisted despite requests from Jai Prakash, North Delhi Mayor. Five of the resident doctors have been on...
Kate Bingham warns against “over-optimism”, says initial Covid-19 vaccines may prove ineffective
Kate Bingham warns that the first generation of Covid vaccines might prove ineffective for some or even fail altogether. Scientists...
Not sufficient COVID vaccines for Europe till 2022, cautions EU
EU officials reportedly stated that only part of its population would be immunized by 2022 European Commission and EU governments...
Karnataka Health Minister ensures availability of COVID-19 vaccines early in 2021
Health Minister believes that a vaccine for COVID-19 would be ready early in 2021. He declared that the state had...
Delhi under strict measures until the COVID-19 vaccine is discovered; Satyendar Jain
The positivity rate was noted at 8.17%, while the death ratio was 1.76%. There are 15,755 beds for Covid sufferers...
American Academy of Paediatrics brings out new guidelines to address Opioid-abuse among pregnant women
Increase in Opioid-use including heroin and fentanyl during pregnancy American Academy of Paediatrics issues new guidelines for opioid medication. Newborns...
Aurobindo Pharma to sell Natrol to New Mountain Capital for $550 mn
Aurobindo Pharma to divest US-based subsidiary Natrol to New Mountain Capital New Mountain Capital acquired profitable Natrol at $550 mn....
